BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35248087)

  • 21. Evaluating dosimetric parameters predictive of hematologic toxicity in cervical cancer patients undergoing definitive pelvic chemoradiotherapy.
    Rahimy E; von Eyben R; Lewis J; Hristov D; Kidd E
    Strahlenther Onkol; 2022 Sep; 198(9):773-782. PubMed ID: 35059758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective single-arm study on the relationship between dose-volume parameters of pelvic functional bone marrow and acute hematological toxicities during intensity-modulated radiotherapy with or without concurrent chemotherapy for uterine cervical/endometrial cancer.
    Chen H; Zhong Q; Liu Y; Li J; Deng W; Wang J; Zhou S; Yu Z; Huang X; Huang Y; Zhen B; Wei J; Zhang W; Ruan X; Xiao L
    Radiat Oncol; 2023 Nov; 18(1):193. PubMed ID: 38012675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [(18)F]FDG-PET standard uptake value as a metabolic predictor of bone marrow response to radiation: impact on acute and late hematological toxicity in cervical cancer patients treated with chemoradiation therapy.
    Elicin O; Callaway S; Prior JO; Bourhis J; Ozsahin M; Herrera FG
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1099-107. PubMed ID: 25442041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study.
    Erpolat OP; Alco G; Caglar HB; Igdem S; Saran A; Dagoglu N; Aslay I; Ozsaran Z; Demirci S; Keven E; Guney Y; Akmansu M; Kilic D; Bayman E; Etiz D; Mandel NM
    Eur J Gynaecol Oncol; 2014; 35(1):62-6. PubMed ID: 24654465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation.
    Sini C; Fiorino C; Perna L; Noris Chiorda B; Deantoni CL; Bianchi M; Sacco V; Briganti A; Montorsi F; Calandrino R; Di Muzio N; Cozzarini C
    Radiother Oncol; 2016 Jan; 118(1):79-84. PubMed ID: 26702990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose to Pelvic Bone Marrow Defined with FDG-PET Predicts for Hematologic Nadirs in Anal Cancer Patients Treated with Concurrent Chemo-radiation.
    Franco P; Arcadipane F; Ragona R; Lesca A; Gallio E; Mistrangelo M; Trino E; Cassoni P; Arena V; Baccega M; Racca P; Faletti R; Rondi N; Morino M; Ricardi U
    Cancer Invest; 2018; 36(5):279-288. PubMed ID: 29953269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensity-Modulated Radiotherapy (IMRT) vs Helical Tomotherapy (HT) in Concurrent Chemoradiotherapy (CRT) for Patients with Anal Canal Carcinoma (ACC): an analysis of dose distribution and toxicities.
    Yeung R; McConnell Y; Warkentin H; Graham D; Warkentin B; Joseph K; Doll CM
    Radiat Oncol; 2015 Apr; 10():92. PubMed ID: 25903798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetric predictors of acute haematological toxicity in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy.
    Lee J; Lin JB; Sun FJ; Lu KW; Lee CH; Chen YJ; Huang WC; Liu HC; Wu MH
    Br J Radiol; 2016 Oct; 89(1066):20160350. PubMed ID: 27556422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation Dose to the Thoracic Vertebral Bodies Is Associated With Acute Hematologic Toxicities in Patients Receiving Concurrent Chemoradiation for Lung Cancer: Results of a Single-Center Retrospective Analysis.
    Barney CL; Scoville N; Allan E; Ayan A; DiCostanzo D; Haglund KE; Grecula J; Williams T; Xu-Welliver M; Otterson GA; Bazan JG
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):748-755. PubMed ID: 29413286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal study of acute haematologic toxicity in cervical cancer patients treated with chemoradiotherapy.
    Zhu H; Zakeri K; Vaida F; Carmona R; Dadachanji KK; Bair R; Aydogan B; Hasan Y; Yashar CM; Mell LK
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):386-93; quiz 394. PubMed ID: 25828068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing intensity modulated radiation therapy and concurrent cisplatin.
    Simpson DR; Song WY; Moiseenko V; Rose BS; Yashar CM; Mundt AJ; Mell LK
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e81-6. PubMed ID: 22516388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Irradiation of anatomically defined pelvic subsites and acute hematologic toxicity in anal cancer patients undergoing chemoradiation.
    Rose B; Mitra D; Hong TS; Jee KW; Niemierko A; Drapek LN; Blaszkowsky LS; Allen JN; Murphy JE; Clark JW; Ryan DP; Wo JY
    Pract Radiat Oncol; 2017; 7(5):e291-e297. PubMed ID: 28462895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monocyte nadir is a possible indicator for neutrophil nadir during lung cancer chemotherapy.
    Moriyama Y; Horita N; Kudo M; Shinkai M; Fujita H; Yamanaka T; Ishigatsubo Y; Kaneko T
    Clin Respir J; 2017 Jul; 11(4):453-458. PubMed ID: 26260239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between changes of pelvic bone marrow fat content and hematological toxicity in concurrent chemoradiotherapy for cervical cancer.
    Wang C; Qin X; Gong G; Wang L; Su Y; Yin Y
    Radiat Oncol; 2022 Apr; 17(1):70. PubMed ID: 35392934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lumbar-sacral bone marrow dose modeling for acute hematological toxicity in anal cancer patients treated with concurrent chemo-radiation.
    Franco P; Ragona R; Arcadipane F; Mistrangelo M; Cassoni P; Rondi N; Morino M; Racca P; Ricardi U
    Med Oncol; 2016 Dec; 33(12):137. PubMed ID: 27815805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematologic Nadirs During Chemoradiation for Anal Cancer: Temporal Characterization and Dosimetric Predictors.
    Lee AY; Golden DW; Bazan JG; Kopec M; Pelizzari CA; Aggarwal S; Chang DT; Liauw SL
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):306-312. PubMed ID: 28068238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of dosimetric parameters and acute toxicity of intensity-modulated and three-dimensional radiotherapy in patients with cervix carcinoma: A randomized prospective study.
    Naik A; Gurjar OP; Gupta KL; Singh K; Nag P; Bhandari V
    Cancer Radiother; 2016 Jul; 20(5):370-6. PubMed ID: 27368915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended-field bone marrow sparing radiotherapy for primary chemoradiotherapy in cervical cancer patients with para-aortic lymphadenopathy: Volumetric-modulated arc therapy versus helical tomotherapy.
    Chen JL; Wang MC; Huang YS; Huang CY; Pan CK; Hsu CY; Lan KH; Kuo SH
    J Xray Sci Technol; 2020; 28(1):111-124. PubMed ID: 31904003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tomotherapy as a neoadjuvant treatment for locally advanced esophageal cancer might increase bone marrow toxicity in comparison with intensity-modulated radiotherapy and volumetric-modulated arc therapy.
    Wang Y; Xiao Q; Zeng B; Ni Q; Liu X; Liu X; Tian L; Sheng C; Peng L; Wang H
    Med Dosim; 2020 Spring; 45(1):e6-e12. PubMed ID: 31176536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies.
    Brixey CJ; Roeske JC; Lujan AE; Yamada SD; Rotmensch J; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1388-96. PubMed ID: 12459361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.